7374

532531

STAR

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

STRIDES PHARMA SCI LTD Share Price Today

STRIDES PHARMA SCI LTD is currently trading at ₹1111.7, up by ₹0.39 from the previous close. The stock touched an intraday high of ₹1121.00 and a low of ₹1107.10 during the latest trading session. Over the past one year, STRIDES PHARMA SCI LTD has delivered a return of 31.42%, while the stock has declined 3.7% in the last one month.

STRIDES PHARMA SCI LTD performance

Today’s low Today’s high
₹ 1107.10 ₹ 1121.00
₹ 1111.30
52 week low 52 week high
₹ 768.65 ₹ 1231.00
₹ 1111.30
Open Price ₹ 1118.00
Prev. Close ₹ 1111.30
Volume (Shares) 70540.00
Total traded value ₹ 783.91
Upper Circuit ₹ 1333.50
Lower Circuit ₹ 889.10
info

Investment Returns

Over 1 Month -3.70% Over 3 Months 23.76% Over 6 Months 19.34% Over 1 Year 31.42%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

STRIDES PHARMA SCI LTD fundamentals


  • Market cap (Cr) 10,243.20
  • P/E Ratio (TTM) 55.93
  • Beta 0.62
  • Book Value / share 356.23
  • Return on equity 85.90%
  • EPS (TTM) 19.92
  • Dividend yield 0.45%
  • Net profit/quarter (Cr) 16.35
info icon alternate text
  • Market cap (Cr) 10,304.40
  • P/E Ratio (TTM) 55.93
  • Beta 0.57
  • Book Value / share 356.23
  • Return on equity 85.90%
  • EPS (TTM) 19.92
  • Dividend yield 0.45%
  • Net profit/quarter (Cr) 16.35
info icon alternate text

STRIDES PHARMA SCI LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 605.74
Operating Expense 583.19
Net Profit 16.35
Net Profit Margin (%) 2.69
Earnings Per Share (EPS) 1.77
EBITDA 78.36
Effective Tax Rate (%) 38.32
Particulars DEC 2025 (Values in Cr)
Revenue 553.63
Operating Expense 522.07
Net Profit 121.90
Net Profit Margin (%) 22.01
Earnings Per Share (EPS) 13.22
EBITDA 184.45
Effective Tax Rate (%) 9.57
Particulars SEP 2025 (Values in Cr)
Revenue 522.15
Operating Expense 510.85
Net Profit 32.04
Net Profit Margin (%) 6.13
Earnings Per Share (EPS) 3.48
EBITDA 76.31
Effective Tax Rate (%) -26.19
Particulars JUN 2025 (Values in Cr)
Revenue 498.62
Operating Expense 483.96
Net Profit 13.35
Net Profit Margin (%) 2.67
Earnings Per Share (EPS) 1.45
EBITDA 68.99
Effective Tax Rate (%) 18.65
Particulars MAR 2025 (Values in Cr)
Revenue 555.96
Operating Expense 539.76
Net Profit 16.13
Net Profit Margin (%) 2.90
Earnings Per Share (EPS) 1.75
EBITDA 80.05
Effective Tax Rate (%) 43.07
Particulars MAR 2026 (Values in Cr)
Revenue 2180.14
Operating Expense 2100.10
Net Profit 183.64
Net Profit Margin (%) 8.42
Earnings Per Share (EPS) 19.92
EBITDA 408.11
Effective Tax Rate (%) 9.58
Particulars MAR 2025 (Values in Cr)
Revenue 2139.42
Operating Expense 2107.50
Net Profit 2886.21
Net Profit Margin (%) 134.90
Earnings Per Share (EPS) 313.68
EBITDA 308.60
Effective Tax Rate (%) 24.24
Particulars MAR 2024 (Values in Cr)
Revenue 1866.12
Operating Expense 1942.40
Net Profit 44.55
Net Profit Margin (%) 2.38
Earnings Per Share (EPS) 4.89
EBITDA 203.85
Effective Tax Rate (%) -5.84
Particulars MAR 2023 (Values in Cr)
Revenue 1854.50
Operating Expense 1988.32
Net Profit 4.68
Net Profit Margin (%) 0.25
Earnings Per Share (EPS) 0.52
EBITDA 167.54
Effective Tax Rate (%) 107.22
Particulars MAR 2022 (Values in Cr)
Revenue 1979.00
Operating Expense 2080.98
Net Profit 180.19
Net Profit Margin (%) 9.10
Earnings Per Share (EPS) 20.08
EBITDA 200.12
Effective Tax Rate (%) -737.70
Particulars MAR 2025 (Values in Cr)
Book Value / Share 276.88
ROE % 150.84
ROCE % 14.28
Total Debt to Total Equity 0.94
EBITDA Margin 18.76
Particulars MAR 2024 (Values in Cr)
Book Value / Share 231.28
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.28
EBITDA Margin 14.55
Particulars MAR 2023 (Values in Cr)
Book Value / Share 243.09
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.32
EBITDA Margin 6.42
Particulars MAR 2022 (Values in Cr)
Book Value / Share 262.70
ROE % -9.42
ROCE % -4.44
Total Debt to Total Equity 1.05
EBITDA Margin -0.34
Particulars MAR 2021 (Values in Cr)
Book Value / Share 309.62
ROE % 8.14
ROCE % 7.32
Total Debt to Total Equity 0.86
EBITDA Margin 17.64
Particulars MAR 2025 (Values in Cr)
Book Value / Share 346.42
ROE % 85.90
ROCE % 4.62
Total Debt to Total Equity 0.43
EBITDA Margin 14.43
Particulars MAR 2024 (Values in Cr)
Book Value / Share 383.84
ROE % 1.43
ROCE % 2.40
Total Debt to Total Equity 0.44
EBITDA Margin 11.23
Particulars MAR 2023 (Values in Cr)
Book Value / Share 380.71
ROE % 0.61
ROCE % 1.87
Total Debt to Total Equity 0.39
EBITDA Margin 9.91
Particulars MAR 2022 (Values in Cr)
Book Value / Share 379.36
ROE % 5.29
ROCE % 1.87
Total Debt to Total Equity 0.33
EBITDA Margin 9.57
Particulars MAR 2021 (Values in Cr)
Book Value / Share 362.18
ROE % 2.44
ROCE % 4.18
Total Debt to Total Equity 0.28
EBITDA Margin 14.88
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 136.78
Total Assets 6048.72
Total Liabilities 6048.72
Total Equity 2586.46
Share Outstanding 9
Price to Book Ratio 1.93
Return on Assets (%) 59.40
Return on Capital (%) 82
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 191.16
Total Assets 5839.75
Total Liabilities 5839.75
Total Equity 2071.70
Share Outstanding 9
Price to Book Ratio 2.04
Return on Assets (%) -1.20
Return on Capital (%) -1.57
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 315.96
Total Assets 6638.42
Total Liabilities 6638.42
Total Equity 2172.88
Share Outstanding 9
Price to Book Ratio 0.75
Return on Assets (%) -3.05
Return on Capital (%) -4.1
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 187.35
Total Assets 6975.86
Total Liabilities 6975.86
Total Equity 2383.31
Share Outstanding 8
Price to Book Ratio 0.91
Return on Assets (%) -6.59
Return on Capital (%) -8.89
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 179.76
Total Assets 7015.02
Total Liabilities 7015.02
Total Equity 2814.00
Share Outstanding 8
Price to Book Ratio 2.33
Return on Assets (%) 3.82
Return on Capital (%) 5.69
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 30.49
Total Assets 5030.94
Total Liabilities 5030.94
Total Equity 3192.73
Share Outstanding 9
Price to Book Ratio 1.93
Return on Assets (%) 57.36
Return on Capital (%) 66.37
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 115.09
Total Assets 5901.87
Total Liabilities 5901.87
Total Equity 3527.60
Share Outstanding 9
Price to Book Ratio 2.04
Return on Assets (%) 0.75
Return on Capital (%) 0.86
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 85.58
Total Assets 5619.74
Total Liabilities 5619.74
Total Equity 3455.05
Share Outstanding 9
Price to Book Ratio 0.75
Return on Assets (%) 0.08
Return on Capital (%) 0.1
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 14.44
Total Assets 5433.85
Total Liabilities 5433.85
Total Equity 3406.68
Share Outstanding 8
Price to Book Ratio 0.91
Return on Assets (%) 3.31
Return on Capital (%) 3.87
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 73.04
Total Assets 5221.33
Total Liabilities 5221.33
Total Equity 3248.05
Share Outstanding 8
Price to Book Ratio 2.33
Return on Assets (%) 1.49
Return on Capital (%) 1.9
Particulars MAR 2025 (Values in Cr)
Net Income 3675.02
Cash from Operations 617.33
Cash from Investing -89.68
Cash from Financing -642.58
Net change in Cash -47.89
Free Cash Flow 859.83
Particulars MAR 2024 (Values in Cr)
Net Income -62.72
Cash from Operations 676.81
Cash from Investing -150.25
Cash from Financing -693.32
Net change in Cash -142.50
Free Cash Flow 794.96
Particulars MAR 2023 (Values in Cr)
Net Income -267.63
Cash from Operations -43.23
Cash from Investing 302.47
Cash from Financing -213.92
Net change in Cash 132.96
Free Cash Flow 51.70
Particulars MAR 2022 (Values in Cr)
Net Income -652.51
Cash from Operations -260.14
Cash from Investing -118.73
Cash from Financing 421.31
Net change in Cash 44.76
Free Cash Flow -116.75
Particulars MAR 2021 (Values in Cr)
Net Income 289.38
Cash from Operations 324.64
Cash from Investing -520.82
Cash from Financing -15.79
Net change in Cash -55.18
Free Cash Flow 622.12
Particulars MAR 2025 (Values in Cr)
Net Income 2905.13
Cash from Operations 298.96
Cash from Investing -137.59
Cash from Financing -370.31
Net change in Cash -86.42
Free Cash Flow 465.16
Particulars MAR 2024 (Values in Cr)
Net Income 40.99
Cash from Operations -67.71
Cash from Investing -69.56
Cash from Financing 93.33
Net change in Cash 9.76
Free Cash Flow 8.70
Particulars MAR 2023 (Values in Cr)
Net Income -64.76
Cash from Operations 141.92
Cash from Investing -182.57
Cash from Financing 10.81
Net change in Cash 69.98
Free Cash Flow 222.60
Particulars MAR 2022 (Values in Cr)
Net Income 21.50
Cash from Operations -304.09
Cash from Investing 18.77
Cash from Financing 250.73
Net change in Cash -13.17
Free Cash Flow -235.92
Particulars MAR 2021 (Values in Cr)
Net Income 111.63
Cash from Operations 115.97
Cash from Investing -275.64
Cash from Financing -48.63
Net change in Cash -41.51
Free Cash Flow 204.71
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 13.14 1.53 243.69 23.12 38.85
BLISS GVS PHARMA LTD. 486.60 39.50 4.32 5160.70 118.35 493.70
CIPLA LTD 1353.85 28.73 3.17 109370.14 1165.55 1672.20
FERMENTA BIOTECH LIMITED 338.20 14.92 2.44 995.36 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 22.24 4.09 243.69 23.12 38.85
AMRUTAJAN HEALTH LTD 546.70 24.50 4.26 1580.54 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8406.60 109.79 24.07 21016.50 7630.00 9850.00
BLISS GVS PHARMA LTD. 486.60 52.49 4.46 5160.70 118.35 493.70

STRIDES PHARMA SCI LTD shareholding pattern

Holding
28.95%
27.91%
28.68%
14.44%
27.27%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

STRIDES PHARMA SCI LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1111.30 0.00 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 1105.50
  • 26 Days 1084.60
  • 10 Days 1092.40
  • 50 Days 1063.50
  • 12 Days 1089.90
  • 100 Days 1014.50
  • 20 Days 1086.80
  • 200 Days 946.50
1109.30 PIVOT
First Support 1096.60 First Resistance 1123.60 Second Support 1082.30 Second Resistance 1136.30 Third Support 1069.60 Third Resistance 1150.60
RSI 56.28 ADX 21.37 MACD 0.85 Williams % R -12.78 Commodity Channel Index (CCI) 34.23
Date 2026-06-19 Week 112641.00 Same Day 28727.00 Month 133294.00
1 Year 0.60 3 Year 0.78
Over 1 Month
-3.70% down
Over 1 Year
31.42% down
Over 3 Months
23.76% down
Over 3 Years
81.79% down
Over 6 Months
19.34% down
Over 5 Years
26.37% down

STRIDES PHARMA SCI LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
22 Jul 2025 4.0 Final 22 Jul 2025 Equity shares
09 Sep 2024 2.5 Final 09 Sep 2024 Equity shares
04 Aug 2023 1.5 Final 04 Aug 2023 Equity shares
05 Aug 2021 2.5 Final 06 Aug 2021 Equity shares
24 Jul 2020 2.0 Final 27 Jul 2020 Equity shares
22 Aug 2019 12.0 Interim 23 Aug 2019 Equity shares
19 Jul 2019 3.0 Final 23 Jul 2019 Equity shares
12 Sep 2018 2.0 Final 15 Sep 2018 Equity shares
07 Sep 2017 4.5 Final 09 Sep 2017 Equity shares
21 Jul 2016 4.0 Final 23 Jul 2016 Equity shares
22 Jul 2015 3.0 Final 24 Jul 2015 Equity shares
16 Oct 2014 105.0 Special 17 Oct 2014 Equity shares
01 Sep 2014 5.0 Final 03 Sep 2014 Equity shares
19 Dec 2013 500.0 Special 20 Dec 2013 Equity shares
30 May 2013 2.0 Final 03 Jun 2013 Equity shares
14 May 2012 2.0 Final 16 May 2012 Equity shares
18 May 2011 1.5 Final 20 May 2011 Equity shares
21 May 2010 1.5 Final 25 May 2010 Equity shares
12 Jun 2007 2.0 Final 14 Jun 2007 Equity shares
06 Jun 2006 0.0 Final 01 Jan 0001 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
22 Jul 2025 4.0 Final 22 Jul 2025 Equity shares
09 Sep 2024 2.5 Final 09 Sep 2024 Equity shares
04 Aug 2023 1.5 Final 04 Aug 2023 Equity shares
05 Aug 2021 2.5 Final 06 Aug 2021 Equity shares
24 Jul 2020 2.0 Final 27 Jul 2020 Equity shares
22 Aug 2019 12.0 Interim 23 Aug 2019 Equity shares
19 Jul 2019 3.0 Final 23 Jul 2019 Equity shares
12 Sep 2018 2.0 Final 15 Sep 2018 Equity shares
07 Sep 2017 4.5 Final 09 Sep 2017 Equity shares
21 Jul 2016 4.0 Final 23 Jul 2016 Equity shares
22 Jul 2015 3.0 Final 24 Jul 2015 Equity shares
16 Oct 2014 105.0 Special 17 Oct 2014 Equity shares
01 Sep 2014 5.0 Final 03 Sep 2014 Equity shares
19 Dec 2013 500.0 Special 20 Dec 2013 Equity shares
30 May 2013 2.0 Final 03 Jun 2013 Equity shares
14 May 2012 2.0 Final 16 May 2012 Equity shares
18 May 2011 1.5 Final 20 May 2011 Equity shares
21 May 2010 1.5 Final 25 May 2010 Equity shares
12 Jun 2007 2.0 Final 14 Jun 2007 Equity shares
06 Jun 2006 0.0 Final 01 Jan 0001 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Strides Pharma Science Ltd?

Answer Field

Strides Pharma Science Ltd share price is for NSE ₹ 1,111.70 & for BSE ₹ 1,113.30 as on Jun 25 2026 09:36 AM.

What is the Market Cap of Strides Pharma Science Ltd Share?

Answer Field

The market cap of Strides Pharma Science Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 25 2026 09:36 AM.

What is the 52 Week High and Low of Strides Pharma Science Ltd?

Answer Field

The 52 Week High and Low of Strides Pharma Science Ltd for NSE is ₹ 1,231.00 and ₹ 768.65 and for BSE is ₹ 1,231.45 and ₹ 769.60.

What is 1 year return for Strides Pharma Science Ltd?

Answer Field

The 1 year returns on the stock has been 33.89%.

What is the P/E Ratio of Strides Pharma Science Ltd Share?

Answer Field

As on Jun 25 2026 09:36 AM the price-to-earnings (PE) ratio for Strides Pharma Science Ltd share is 55.93.

What is the PB ratio of Strides Pharma Science Ltd Share?

Answer Field

As on Jun 25 2026 09:36 AM, the price-to-book (PB) ratio for Strides Pharma Science Ltd share is 356.23.

How to Buy Strides Pharma Science Ltd Share?

Answer Field

You can trade in Strides Pharma Science Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Strides Pharma Science Ltd Share on Bajaj Broking App?

Answer Field

To buy Strides Pharma Science Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Strides Pharma Science Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|